Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma Extensive Disease × Drug Therapy × Clear all

NCT04449861 2024-11-27

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

Phase 3 Completed

166 enrolled 20 charts

Small Cell Lung Carcinoma Extensive Disease